Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
10 pending office actions • 9 clients • 10 examiners • 8 art units • 0 of 10 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
The Wilmington office of McCarter & English, LLP has handled 576 career applications in the Biotechnology & Pharmaceuticals technology area. The firm has a resolved allowance rate of 77.72 percent. On average, it takes 3.86 office actions to reach an allowance. There are 8 pending office actions currently.
The Wilmington office's performance in biotechnology is marked by a resolved allowance rate of 77.72 percent across 576 career applications. This success is reached with an average of 3.86 office actions per allowance, reflecting a consistent prosecution process. With 8 pending office actions, the office remains active in the biotechnology and pharmaceutical sectors.
The management of these career applications reflects a steady practice in this technology area. The average number of office actions per allowance provides a benchmark for the office's efficiency. These data points offer a comprehensive view of the office's effectiveness in securing patent rights for its clients.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (10%) |
| §101 + other | 1 (10%) |
| §103 only | 3 (30%) |
| §102 only | 1 (10%) |
| Double-patenting only | 1 (10%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTALVO, CARLOS FERNANDO | 1 | 15.0% | -1.1% |
| BROOME, SHARRIEF I | 1 | 81.5% | +4.5% |
| GRAHAM, CHANTEL LORAN | 1 | 71.7% | +11.5% |
| MISIASZEK, AMBER ALTSCHUL | 1 | 46.9% | +24.3% |
| CLEMMONS, STEVE M | 1 | 69.5% | +21.0% |
| ALLEY, GENEVIEVE S | 1 | 60.3% | +48.2% |
| MERTZ, PREMA MARIA | 1 | 71.7% | +35.4% |
| RIEGLER, PATRICK F | 1 | 54.9% | +31.2% |
| SAEED, ALI S | 1 | 31.3% | +35.8% |
| MORNHINWEG, JEFFREY P | 1 | 36.3% | +32.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18411752 | Engine, System, and Method of Providing Automated Risk Mitigation | RIEGLER, PATRICK F | 49d overdue |
| 19171024 | ROBUST VIRTUAL COMMUNICATIONS INFORMATICS PLATFORM | MONTALVO, CARLOS FERNANDO | — |
| 18997270 | LIGHT-CANCELLING ARTICLE AND PROJECTION APPARATUS | BROOME, SHARRIEF I | — |
| 18919303 | EVALUATING TOPIC TREATMENT IN ELECTRONIC COMMUNICATIONS | MISIASZEK, AMBER ALTSCHUL | — |
| 18368599 | COMPOSITIONS COMPRISING AND METHODS OF USING 1,3-PROPANEDIOL, TO IMPROVE SWEETNESS AND/OR REDUCE BITTERNESS OF SWEETENERS | MORNHINWEG, JEFFREY P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18411752 | Engine, System, and Method of Providing Automated Risk Mitigation | RIEGLER, PATRICK F | 49d overdue |
| 18512349 | DROPROPIZINE IN COMBINATION WITH AMBROXOL IN THE DOSAGE FORM OF SYRUP AND TABLETS | SAEED, ALI S | 31d overdue |
| 18711261 | METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS | ALLEY, GENEVIEVE S | 69d |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | GRAHAM, CHANTEL LORAN | — |
| 18919303 | EVALUATING TOPIC TREATMENT IN ELECTRONIC COMMUNICATIONS | MISIASZEK, AMBER ALTSCHUL | — |
| 18785017 | SKATEBOARD TRUCK ASSEMBLY | CLEMMONS, STEVE M | — |
| 18597286 | METHODS OF TREATING ATOPIC DERMATITIS | MERTZ, PREMA MARIA | — |
| 18368599 | COMPOSITIONS COMPRISING AND METHODS OF USING 1,3-PROPANEDIOL, TO IMPROVE SWEETNESS AND/OR REDUCE BITTERNESS OF SWEETENERS | MORNHINWEG, JEFFREY P | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Highspot | 2 |
| Holotronica Limited | 1 |
| University of Delaware | 1 |
| Djll Holdings, LLC | 1 |
| Christiana Care Health System | 1 |
| Receptos LLC | 1 |
| Josh Kelso | 1 |
| Productos Farmaceuticos, S.A. DE C.V. | 1 |
| Primient Covation LLC | 1 |
| Art Unit | Apps |
|---|---|
| 3629 | 1 |
| 2872 | 1 |
| 3682 | 1 |
| 1617 | 1 |
| 1646 | 1 |
| 2171 | 1 |
| 1616 | 1 |
| 1793 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19171024 | ROBUST VIRTUAL COMMUNICATIONS INFORMATICS PLATFORM | Highspot, Inc. | MONTALVO, CARLOS FERNANDO | 3629 | §101§103 | Non-Final OA | — | Pending | Apr 04, 2025 |
| 18997270 | LIGHT-CANCELLING ARTICLE AND PROJECTION APPARATUS | Holotronica Limited | BROOME, SHARRIEF I | 2872 | §102§103 | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18948419 | MICROWAVE-ASSISTED CATALYTIC PYROLYSIS PROCESS AND REACTOR FOR SELECTIVELY CONVERTING ADDITIVE-CONTAINING PLASTIC TO ALKENES AND ALKANES | UNIVERSITY OF DELAWARE | GRAHAM, CHANTEL LORAN | §103 | Non-Final OA | — | Pending | Nov 14, 2024 | |
| 18919303 | EVALUATING TOPIC TREATMENT IN ELECTRONIC COMMUNICATIONS | Highspot, Inc. | MISIASZEK, AMBER ALTSCHUL | 3682 | §101 | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18785017 | SKATEBOARD TRUCK ASSEMBLY | Djll Holdings, LLC | CLEMMONS, STEVE M | §103 | Final Rejection | — | Pending | Jul 26, 2024 | |
| 18711261 | METHODS FOR INTRATUMORAL DELIVERY OF CRISPR/CAS SYSTEMS | Christiana Care Gene Editing Institute, Inc. | ALLEY, GENEVIEVE S | 1617 | §102 | Non-Final OA | 69d | Pending | May 17, 2024 |
| 18597286 | METHODS OF TREATING ATOPIC DERMATITIS | Receptos LLC | MERTZ, PREMA MARIA | 1646 | DP | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18411752 | Engine, System, and Method of Providing Automated Risk Mitigation | Josh Kelso | RIEGLER, PATRICK F | 2171 | §102§103 | Final Rejection | 49d overdue | Pending | Jan 12, 2024 |
| 18512349 | DROPROPIZINE IN COMBINATION WITH AMBROXOL IN THE DOSAGE FORM OF SYRUP AND TABLETS | Productos Farmaceuticos, S.A. De C.V. | SAEED, ALI S | 1616 | §103 | Non-Final OA | 31d overdue | Pending | Nov 17, 2023 |
| 18368599 | COMPOSITIONS COMPRISING AND METHODS OF USING 1,3-PROPANEDIOL, TO IMPROVE SWEETNESS AND/OR REDUCE BITTERNESS OF SWEETENERS | Primient Covation LLC | MORNHINWEG, JEFFREY P | 1793 | §102§103 | Non-Final OA | — | Pending | Sep 15, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial